Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score
Publication date
2021ISSN
0007-1323
Abstract
Since the beginning of the COVID-19 pandemic tens of millions of operations have been cancelled1 as a result of excessive postoperative pulmonary complications (51.2 per cent) and mortality rates (23.8 per cent) in patients with perioperative SARS-CoV-2 infection2. There is an urgent need to restart surgery safely in order to minimize the impact of untreated non-communicable disease. As rates of SARS-CoV-2 infection in elective surgery patients range from 1–9 per cent3–8, vaccination is expected to take years to implement globally9 and preoperative screening is likely to lead to increasing numbers of SARS-CoV-2-positive patients, perioperative SARS-CoV-2 infection will remain a challenge for the foreseeable future. To inform consent and shared decision-making, a robust, globally applicable score is needed to predict individualized mortality risk for patients with perioperative SARS-CoV-2 infection. The authors aimed to develop and validate a machine learning-based risk score to predict postoperative mortality risk in patients with perioperative SARS-CoV-2 infection.
Document Type
Article
Document version
Published version
Language
English
Subject (CDU)
61 - Medical sciences
616.9 - Communicable diseases. Infectious and contagious diseases, fevers
Keywords
Pages
19
Publisher
Oxford University Press
Collection
108
Is part of
British Journal of Surgery
Citation
COVIDSurg Collaborative. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score. British Journal of Surgery, 2021, 108(11), p. 1274-1292. Disponible en: <https://academic.oup.com/bjs/article/108/11/1274/6316029>. Fecha de acceso: 21 oct. 2022. DOI: 10.1093/bjs/znab183
Note
This report was funded by a National Institute for Health Research (NIHR) Global Health Research Unit Grant (NIHR 16.136.79), Association of Coloproctology of Great Britain and Ireland, Bowel & Cancer Research, Bowel Research UK, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, Medtronic, NIHR Academy, The Urology Foundation, Sarcoma UK, Vascular Society for Great Britain and Ireland, Yorkshire Cancer Research, and the MRC Health Data Research UK (HDRUK/CFC/01), an initiative funded by UK Research and Innovation, Department of Health and Social Care (England) and the devolved administrations, and leading medical research charities. L.B.M. and G.V.G. also acknowledge the Wellcome Trust 4-year studentship programme in mechanisms of inflammatory disease (MIDAS; 215182/Z/19/Z). The funders had no role in study design, data collection, analysis and interpretation, or writing of this report. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the UK Department of Health and Social Care.
Link to the related item
This item appears in the following Collection(s)
- Ciències de la Salut [973]
Rights
© This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/

